Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2002
10/31/2002WO2002085866A1 Novel compounds
10/31/2002WO2002085863A1 Novel compounds of the family of 3-alkyl-(4,5 diphenyl-imidazol-1-yl) and their use as soothing agents
10/31/2002WO2002085861A1 Imidazolidine compounds and their use as cxcr3 antagonists
10/31/2002WO2002085860A1 Pyrazole derivatives for treating hiv
10/31/2002WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002WO2002085854A1 5-aryl-1.3.3.-trimethyl-2-methylene-indoline derivatives and salts thereof, methods for the production and use of said compounds for the temporary coloration of fibres
10/31/2002WO2002085851A1 Pyrrole derivative
10/31/2002WO2002085850A1 Cyclic amidine derivative
10/31/2002WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002WO2002085360A1 Optimized procedures for the manufacture of paroxetine salts
10/31/2002WO2002085357A1 Nociceptin analogs
10/31/2002WO2002085354A1 Spiroindene and spiroindane compounds
10/31/2002WO2002085351A1 Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer
10/31/2002WO2002085301A2 Indole, azaindole and related heterocyclic amidopiperazine derivatives
10/31/2002WO2002070499A3 Prodrugs derivatives of the ascorbic acid suitable to the passage of the hematoencephalic barrier
10/31/2002WO2002069895A3 Heterocyclic analgesic compounds and methods of use thereof
10/31/2002WO2002059089A3 Process for the preparation of heterocyclic indene analogs
10/31/2002WO2002048105A3 Aryloxy piperidinyl derivatives for the treatment of depression
10/31/2002WO2001052746A9 Versatile hydrophilic dyes
10/31/2002US20020161240 Synthetic multimerizing agents
10/31/2002US20020161036 Chalcone coumarins
10/31/2002US20020161034 Spiro-pyran compounds; use as pesticides and herbicides
10/31/2002US20020161024 Administering 2-(piperidin-2,6-dion-3-yl),4-amino-isoindolin-1-one to treat an eye condition
10/31/2002US20020161011 Potassium channel inhibitors
10/31/2002US20020161009 Use of selective antagonists of the alpha1b-adrenergic receptor for improvement of sexual dysfunction
10/31/2002US20020161005 Nitrogen heterocycle compounds
10/31/2002US20020161004 Antiinflammation agents
10/31/2002US20020161000 Treating diseases resulting from tissue breakdown such as heart disease, multiple sclerosis, osteo- and rheumatoid arthritis, atherosclerosis, and osteoporosis
10/31/2002US20020160996 Benzofuran substituted by a fused nitrogen-containing heterocyclic ring such as isoindoline; inhibits cytotoxicity of beta-amyloid; Alzheimer's or Parkinson's disease
10/31/2002US20020160984 For example, 2,3-dihydro-1H-benz(de)isoquinolin-1-one; treating diabetes, cancer, radiosensitizing tumor cells, cardiovascular disorders, septic shock, inflammatory bowel disease, senescent cells
10/31/2002US20020160983 Substituted benzopyranones as telomerase inhibitors
10/31/2002DE10120619A1 2-(5-(4-Fluorphenyl)-3-pyridylmethylaminomethyl-chroman 2- (5- (4-fluorophenyl) -3-pyridylmethylaminomethyl-chromane
10/31/2002CA2445236A1 Piperazino-derivatives and their use as pde4 inhibitor
10/31/2002CA2445233A1 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002CA2445188A1 Arylindenopyridines with pde inhibiting activity
10/31/2002CA2444381A1 Novel compounds
10/31/2002CA2443600A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002CA2442591A1 Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer
10/30/2002EP1252162A1 Alpha v integrin receptor antagonists
10/30/2002EP1252157A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
10/30/2002EP1252156A1 Blockade of voltage dependent sodium channels
10/30/2002EP1252155A1 Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8 4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
10/30/2002EP1252153A1 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
10/30/2002EP1252146A1 Amide compounds for inhibiting protein kinases
10/30/2002EP1252145A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/30/2002EP1252143A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives
10/30/2002EP1252140A1 Pyrrolecarboxamides and pyrrolethioamides as fungicides
10/30/2002EP1252139A1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
10/30/2002EP1159254A4 Oxyalkylene-substituted aminophenol intermediate
10/30/2002EP1000172A4 Detection of targets with green fluorescent protein and fluorescent variants thereof
10/30/2002EP0991410B1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
10/30/2002EP0854863B1 Esters and amides as pla2 inhibitors
10/30/2002EP0852225B1 Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
10/30/2002CN1377347A 药学活性磺酰胺衍生物 Pharmaceutically active sulfonamide derivatives
10/30/2002CN1377346A Z-pyrazoline-5-ones
10/30/2002CN1377268A Cell adhesion inhibitors
10/30/2002CN1377263A Neuropathy improves containing nitrogenous compounds as the active ingredient
10/30/2002CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/30/2002CN1093539C Process for synthesizing beta-halobutenolide
10/30/2002CN1093536C 5-lipoxygenase inhibitor
10/29/2002US6472536 Such as 2-(4-(4-cyclopentyloxybenzyl)phenyl)amino-imidazoline; antinociceptive agents; ip receptor antagonists; treating inflammatory pain
10/29/2002US6472529 Viricides
10/29/2002US6472526 Shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts or isomers thereof, in pharmaceutical composition and intermediates
10/29/2002US6472425 Methods for treating female sexual dysfunctions
10/29/2002US6472418 Non-peptide NK1 receptors antagonists
10/29/2002US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
10/29/2002US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/29/2002US6472405 Glycoprotein IIB/IIIA antagonists
10/29/2002US6472404 HIV protease inhibitors
10/29/2002US6472403 αV integrin receptor antagonists
10/29/2002US6472397 Nitrogen-containing heterocyclic compounds having antiplatelet aggregation effect and medicinal use thereof
10/29/2002US6472396 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/29/2002US6472394 MCH antagonists and their use in the treatment of obesity
10/29/2002US6472392 Triazole compounds and the use thereof as dopamine-D3 -ligands
10/29/2002US6472391 Nitrogen-containing heterocyclic compounds
10/29/2002US6472349 Pyridine-2,3-dicarboxylic acid diamides
10/29/2002US6472348 Pyridone derivatives and herbicides
10/29/2002CA2342471C Heterocyclecarbonylmethyl amine intermediates
10/24/2002WO2002083666A1 Substituted benzofuran-2-carboxamides derivatives
10/24/2002WO2002083651A2 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
10/24/2002WO2002083645A1 Novel compounds
10/24/2002WO2002083638A1 Process for the production of atorvastatin calcium in amorphous form
10/24/2002WO2002083637A1 Process for the production of amorphous atorvastatin calcium
10/24/2002WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002WO2002083143A1 Cxcr3 antagonists
10/24/2002WO2002083134A1 Aryl and biaryl piperidines used as mch antagonists
10/24/2002WO2002083123A1 Aurones as telomerase inhibitors
10/24/2002WO2002083111A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
10/24/2002WO2002083067A2 Prodrugs via acylation with cinnamate
10/24/2002WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002US20020156294 Factory scale process for producing crystalline atorvastatin trihydrate hemi calcium salt
10/24/2002US20020156281 Anticholesterol agents; cardiovascular disorders; antilipemic agents; restenosis; dietetics
10/24/2002US20020156117 Receptor-avid exogenous optical contrast and therapeutic agents
10/24/2002US20020156115 Pyrazolylacetic acid derivatives
10/24/2002US20020156111 Substituted bicyclic compounds
10/24/2002US20020156110 Anticancer, antiproliferative and antiarthritic agents
10/24/2002US20020156102 Piperidine amides as modulators of chemo kine receptor activity
10/24/2002US20020156098 Antiprotozoa agents, parasiticides
10/24/2002US20020156087 Pyrimidine or pyridine derivatives
1 ... 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 ... 694